About ASMB

Assembly Biosciences, Inc.is a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome. The HBV program is focused on advancing a new class of potent, oral core inhibitors that have the potential to increase cure rates for chronically infected patients. Themicrobiome program is developing novel oral live synthetic biotherapeutic candidates with Assembly's fully integrated platform, including a robust process for strain identification and selection, GMP banking and production, and targeted delivery to the lower gastrointestinal tract with the GEMICEL technology.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ASMB is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
URTY ProShares UltraPro Russell2000 90.2 M 9.0207E+07 1,996 1996 0.0% 3.11682E-05 9 K 9183
UWM ProShares Ultra Russell2000 162.4 M 1.62362E+08 1,996 1996 0.01% 6.0581E-05 21 K 20502
TILT FlexShares Mornigstar US Market Factors Tilt Index Fund ETF 1.4 B 1.39638E+09 1,982 1982 0.0% 3.1E-05 42 K 42369
FHLC Fidelity MSCI Health Care Index ETF 1.5 B 1.5E+09 371 371 0.01% 9.32275E-05 144 K 143634
ITOT iShares Core S&P Total U.S. Stock Market ETF 20.4 B 2.04474E+10 3,545 3545 0.0% 0 261 K 261474
IWC iShares Microcap ETF 858.7 M 8.58676E+08 1,430 1430 0.08% 0.0008 713 K 713452
IWM iShares Russell 2000 ETF 41.2 B 4.12382E+10 1,985 1985 0.01% 0.0001 6.1 M 6117520
IWO iShares Russell 2000 Growth ETF 8.9 B 8.9462E+09 1,230 1230 0.03% 0.0003 2.6 M 2591700
IWV iShares Russell 3000 ETF 9.3 B 9.30666E+09 2,929 2929 0.0% 0 84 K 83562
LABU Direxion Daily S&P Biotech Bull 3X Shares 632.7 M 6.32748E+08 131 131 0.03% 0.000290688 596 K 595527
XBI SPDR Series Trust SPDR S&P Biotech ETF 4.3 B 4.2649E+09 122 122 0.15% 0.00148442 6.1 M 6124670